Holen Sie sich die Stockscreener-App
16.93
3.87%
0.63
Handel nachbörslich:
16.80
-0.13
-0.77%
Schlusskurs vom Vortag:
$16.30
Offen:
$16.81
24-Stunden-Volumen:
261.66K
Relative Volume:
0.74
Marktkapitalisierung:
$625.78M
Einnahmen:
$11.88M
Nettoeinkommen (Verlust:
$-162.08M
KGV:
-1.3561
EPS:
-12.484
Netto-Cashflow:
$-156.43M
1W Leistung:
+12.49%
1M Leistung:
-8.78%
6M Leistung:
+50.22%
1J Leistung:
+27.39%
1-Tages-Spanne:
$16.48
$17.80
1-Wochen-Bereich:
$15.44
$17.80
52-Wochen-Spanne:
$8.72
$27.41
Crescent Biopharma Inc Stock (CBIO) Company Profile
Firmenname
Crescent Biopharma Inc
Sektor
Branche
Telefon
617-430-5595
Adresse
300 FIFTH AVENUE, WALTHAM, CA
Compare CBIO vs VRTX, REGN, ARGX, RVMD, ALNY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBIO
Crescent Biopharma Inc
|
16.93 | 602.49M | 11.88M | -162.08M | -156.43M | -12.48 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Crescent Biopharma Inc Stock (CBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-28 | Eingeleitet | Piper Sandler | Overweight |
| 2026-01-21 | Eingeleitet | Guggenheim | Buy |
| 2025-08-25 | Eingeleitet | Jefferies | Buy |
| 2025-08-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-14 | Eingeleitet | Wedbush | Outperform |
| 2025-06-25 | Eingeleitet | Stifel | Buy |
| 2025-03-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-03-11 | Eingeleitet | Noble Capital Markets | Outperform |
| 2024-07-26 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-12-22 | Eingeleitet | CapitalOne | Overweight |
| 2021-11-12 | Hochstufung | Jefferies | Hold → Buy |
| 2021-04-29 | Fortgesetzt | Stephens | Overweight |
| 2021-02-10 | Eingeleitet | Piper Sandler | Overweight |
| 2020-05-21 | Eingeleitet | Raymond James | Outperform |
| 2019-11-14 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2019-08-05 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2019-08-05 | Herabstufung | SunTrust | Buy → Hold |
| 2019-04-12 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-01-04 | Eingeleitet | Oppenheimer | Outperform |
| 2018-12-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-02-12 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-12-08 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | Eingeleitet | Chardan Capital Markets | Buy |
| 2017-06-06 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-07-26 | Eingeleitet | SunTrust | Buy |
| 2016-06-30 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-03-17 | Bestätigt | Stifel | Buy |
Alle ansehen
Crescent Biopharma Inc Aktie (CBIO) Neueste Nachrichten
Crescent Biopharma Ord Shs (CBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Crescent Biopharma Market Sentiment - Benzinga España
CBIO|Crescent Biopharma Ord Shs|Price:16.300|Chg%:-0.730 - TradingKey
Crescent Biopharma (CBIO) Short Interest & Short Float | Updated Jul 2026 - MarketBeat
Crescent Biopharma grants inducement stock options for 52,500 shares at $15.83 each - Bitget
Crescent Biopharma Announces Grants of Inducement Awards - The Manila Times
Two Crescent Biopharma Employees Receive 52,500 Stock Options - Stock Titan
Fairmount Healthcare Fund II LP acquires 853,450 Crescent Biopharma shares for $12.38 million - Bitget
Fairmount Funds' $12 Million Bet on Crescent Biopharma: A Strong Signal Amidst Volatility - Kavout | AI
Insider fund at Crescent Biopharma (NASDAQ: CBIO) buys 1.38M shares, warrants - Stock Titan
Fairmount Funds holds 16.5% of Crescent Biopharma (CBIO) after July 2026 deal - Stock Titan
Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Kazia Therapeutics (KZIA) and Crescent Biopharma (CBIO) - The Globe and Mail
Crescent Biopharma (CBIO) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Crescent Biopharma closes $143.7 million public offering - Investing.com
Crescent Biopharma closes $143.7 million public offering By Investing.com - Investing.com Nigeria
Crescent Biopharma (CBIO) Proxy filing Summary - Quartr
Crescent Biopharma Announces Closing of Public Offering of - GlobeNewswire
Crescent Biopharma (CBIO) Bank of America Global Healthcare Conference 2026 Summary - Quartr
H.C. Wainwright Maintains Crescent Biopharma(CBIO.US) With Hold Rating - Moomoo
Crescent Biopharma closes $143.7M public offering - scanx.trade
Form 424B5 Crescent Biopharma Inc For: 15 July By Investing.com - Investing.com Canada
Crescent Bi raises up to $133.5M in registered offering of 8.09M shares and pre-funded warrants - TradingView
Crescent Biopharma (Nasdaq: CBIO) prices $125.0 million stock and warrant sale - Stock Titan
Form 424B5 CRESCENT BIOPHARMA, INC. - StreetInsider
Crescent Biopharma (Nasdaq: CBIO) targets approximately $115.9 million raise - Stock Titan
Crescent Biopharma Prices $125 Million Common, Warrant Offering - marketscreener.com
Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants - The Manila Times
Crescent Biopharma, Inc. Files 8-K with SEC – Ordinary Shares (CBIO) Listed on NASDAQ, Key Company Details for July 2026 141649 – Minichart - Minichart
Form 424B5 Crescent Biopharma Inc For: 14 July - Investing.com UK
Crescent Biopharma launches public offering of ordinary shares By Investing.com - Investing.com Nigeria
Crescent Biopharma prices $125M public offering at $14.50/share - Investing.com
Crescent Biopharma Underwriters Have Option for Nearly 1.3M Additional Shares >CBIO - Moomoo
Crescent Biopharma prices $125M public offering of shares and pre-funded warrants - Pluang
Crescent Biopharma Expects Offering to Close July 16 >CBIO - Moomoo
Crescent Biopharma Also Offering Certain Investors Prefunded Warrants to Buy 525,897 Shares >CBIO - Moomoo
Crescent Biopharma prices $125M public offering at $14.50/share By Investing.com - Investing.com India
Crescent Biopharma Prices $125 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - Quiver Quantitative
Crescent Biopharma Sets $14.50 Price for 8.1M Shares - Stock Titan
Crescent Biopharma files for underwritten offering of ordinary shares and pre-funded warrants - MSN
Crescent Biopharma launches public offering of ordinary shares - Investing.com
Crescent Biopharma Launches Offering of Common Shares, Warrants - marketscreener.com
Form 424B5 Crescent Biopharma Inc For: 14 July By Investing.com - Investing.com India
Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants - The Manila Times
Crescent Biopharma (NASDAQ: CBIO) reports $171.6M preliminary cash as of June 30, 2026 - Stock Titan
Crescent Biopharma (NASDAQ: CBIO) details share and pre-funded warrant deal - Stock Titan
Price to earnings forward of Crescent Biopharma, Inc. – NASDAQ:CBIO - TradingView
symbol__ Stock Quote Price and Forecast - CNN
[EFFECT] CRESCENT BIOPHARMA, INC. SEC Filing - Stock Titan
Crescent Biopharma Inc (CBIO) - MSN
Crescent Biopharma (CBIO) Morgan Stanley 23rd Annual Global Healthcare Conference summary - Quartr
Enterprise value to EBITDA forward of Crescent Biopharma, Inc. – NASDAQ:CBIO - TradingView
Finanzdaten der Crescent Biopharma Inc-Aktie (CBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):